AI-generated summary
The authors treated 60 atrophic scars from cutaneous leishmaniasis on the faces of 40 patients with a fractional CO2 laser over three monthly sessions. Patients and physicians rated healing at several follow-up visits, and most reported moderate to excellent improvement by 3 and 6 months after treatment. The study had no control group, and the authors reported no significant adverse effects.
- Participants
- 40
- Who or what was studied
- 40 patients with 60 atrophic scars from cutaneous leishmaniasis on the face
- Limits stated in the abstract
- The abstract does not describe a control group, and the authors report no details of the comparison used to judge healing beyond patient and observer ratings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.